ArticleBMC cancer2022

Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up.

Cihan Uras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.